luracor lurasidone hydrochloride 40 mg film-coated tablet bottle
pharmacor pty ltd - lurasidone hydrochloride, quantity: 40 mg - tablet, film coated - excipient ingredients: citric acid; lactose monohydrate; magnesium stearate; povidone; croscarmellose sodium; mannitol; pregelatinised maize starch; titanium dioxide; hypromellose; macrogol 400 - lurasidone hydrochloride film-coated tablets are indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).
pharmacor lurasidone lurasidone hydrochloride 40 mg film-coated tablet blister pack
pharmacor pty ltd - lurasidone hydrochloride, quantity: 40 mg - tablet, film coated - excipient ingredients: magnesium stearate; povidone; lactose monohydrate; citric acid; pregelatinised maize starch; croscarmellose sodium; titanium dioxide; hypromellose; macrogol 400 - lurasidone hydrochloride film-coated tablets are indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).
pharmacor lurasidone lurasidone hydrochloride 40 mg film-coated tablet bottle
pharmacor pty ltd - lurasidone hydrochloride, quantity: 40 mg - tablet, film coated - excipient ingredients: lactose monohydrate; pregelatinised maize starch; mannitol; citric acid; croscarmellose sodium; povidone; magnesium stearate; titanium dioxide; hypromellose; macrogol 400 - lurasidone hydrochloride film-coated tablets are indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).
luracor lurasidone hydrochloride 20 mg film-coated tablet blister pack
pharmacor pty ltd - lurasidone hydrochloride, quantity: 20 mg - tablet, film coated - excipient ingredients: citric acid; croscarmellose sodium; lactose monohydrate; povidone; mannitol; magnesium stearate; pregelatinised maize starch; titanium dioxide; hypromellose; macrogol 400 - lurasidone hydrochloride film-coated tablets are indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).
luracor lurasidone hydrochloride 20 mg film-coated tablet bottle
pharmacor pty ltd - lurasidone hydrochloride, quantity: 20 mg - tablet, film coated - excipient ingredients: magnesium stearate; citric acid; povidone; croscarmellose sodium; lactose monohydrate; pregelatinised maize starch; mannitol; titanium dioxide; hypromellose; macrogol 400 - lurasidone hydrochloride film-coated tablets are indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).
pharmacor lurasidone lurasidone hydrochloride 20 mg film-coated tablet blister pack
pharmacor pty ltd - lurasidone hydrochloride, quantity: 20 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; citric acid; lactose monohydrate; mannitol; magnesium stearate; povidone; pregelatinised maize starch; titanium dioxide; hypromellose; macrogol 400 - lurasidone hydrochloride film-coated tablets are indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).
pharmacor lurasidone lurasidone hydrochloride 20 mg film-coated tablet bottle
pharmacor pty ltd - lurasidone hydrochloride, quantity: 20 mg - tablet, film coated - excipient ingredients: povidone; mannitol; pregelatinised maize starch; lactose monohydrate; citric acid; magnesium stearate; croscarmellose sodium; titanium dioxide; hypromellose; macrogol 400 - lurasidone hydrochloride film-coated tablets are indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).
ilium thiopentone
troy laboratories pty limited - thiopental sodium - thiopental sodium 1,000 g/kg - anaesthetic
thiopental injection bp 500 mg powder for solution for injection
rotexmedica gmbh arzneimittelwerk bunsenstrasse 4, 22946 trittau, germany - thiopental sodium - powder for solution for injection - 1 vial contains 500 mg thiopental sodium - general anesthetics: plain barbiturates
pentothal thiopental sodium 500 mg powder for injection vial
link medical products pty ltd t/a link pharmaceuticals - thiopental sodium, quantity: 0.5 g - injection, powder for - excipient ingredients: - indications as at 08 dec 1993 : pentothal may be used : 1. as the sole anaesthetic agent for brief surgical procedures; 2. for the induction of anaesthesia prior to the administration of other anaesthetic agents; 3. for the short-term control of condvulsive states; 4. to supplement regional anaesthesia or low potency agents such as nitrous oxide.